CD5 and B-cell chronic lymphocytic leukemia: CML is a myeloproliferative neoplasm driven by the BCR::ABL1 (breakpoint cluster region-AbLeson fusion gene) fusion tyrosine kinase, whereas CLL is a lymphoproliferative disorder of monoclonal CD5+ve B lymphocytes.